Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway

Pathology and Oncology Research

Volumn 22, Issue 3, 2016, Pages 471-476

  Wu, Xiaojuan ^a   Sun, Limin ^b   Wang, Xiao ^a   Su, Peng ^a   Li, Zhishuang ^a   Zhang, Chunyan ^a   Wang, Yan ^a   Gao, Peng ^a   Ma, Rong ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Jiaotong Hospital   (China)

Author keywords

Invasive breast cancer; Metastasis; MMP 9; mPR ; p Akt

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN MPRALPHA; TUMOR MARKER; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROGESTIN RECEPTOR ALPHA, HUMAN;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; BREAST; BREAST TUMOR; FEMALE; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; BIOMARKERS, TUMOR; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 84948151985     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-015-0023-8     Document Type: Article

References (21)

1. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, MacDonald IC, Groom AC (2001) Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10(2):243–255 vii
2. Basu A, Rowan BG (2005) Genes related to estrogen action in reproduction and breast cancer. Front Biosci: J Virtual Libr 10:2346–2372
3. Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, et al. (2007) Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol 21(6):1335–1358. doi:10.1210/me.2006-0304
4. Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, et al. (2006) Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 20(7):1519–1534. doi:10.1210/me.2005-0243
5. Dressing GE, Alyea R, Pang Y, Thomas P (2012) Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm Cancer 3(3):101–112. doi:10.1007/s12672-012-0106-x
6. Alizadeh AA, Ross DT, Perou CM, van de Rijn M (2001) Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195(1):41–52. doi:10.1002/path.889
7. Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, et al. (2009) Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer 115(8):1605–1612. doi:10.1002/cncr.24173
8. Illemann M, Bird N, Majeed A, Sehested M, Laerum OD, Lund LR, et al. (2006) MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res: MCR 4(5):293–302. doi:10.1158/1541-7786.MCR-06-0003
9. Gompel A (2012) Micronized progesterone and its impact on the endometrium and breast vs. progestogens. Climacteric: J Int Menopause Soc 15(Suppl 1):18–25. doi:10.3109/13697137.2012.669584
10. L’Hermite M (2013) HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric: J Int Menopause Soc. 16(Suppl 1):44–53. doi:10.3109/13697137.2013.808563
11. Kuhl H, Schneider HP (2013) Progesterone–promoter or inhibitor of breast cancer. Climacteric: J Int Menopause Soc 16(Suppl 1):54–68. doi:10.3109/13697137.2013.768806
12. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P (2003) Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci U S A 100(5):2231–2236. doi:10.1073/pnas.0336132100
13. Zhu Y, Bond J, Thomas P (2003) Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A 100(5):2237–2242. doi:10.1073/pnas.0436133100
14. Thomas P, Pang Y, Dong J, Groenen P, Kelder J, de Vlieg J, et al. (2007) Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology 148(2):705–718. doi:10.1210/en.2006-0974
15. Lyons TJ, Villa NY, Regalla LM, Kupchak BR, Vagstad A, Eide DJ (2004) Metalloregulation of yeast membrane steroid receptor homologs. Proc Natl Acad Sci U S A 101(15):5506–5511. doi:10.1073/pnas.0306324101
16. van Beijnum JR, Petersen K, Griffioen AW (2009) Tumor endothelium is characterized by a matrix remodeling signature. Front Biosci. 1:216–225
17. Youssef NS, Hakim SA (2014) Association of fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of egyptian women. Diagn Pathol. 9:136. doi:10.1186/1746-1596-9-136
18. Xue B, Huang W, Yuan X, Xu B, Lou Y, Zhou Q, et al. (2015) YSY01A, a novel proteasome inhibitor, induces cell cycle arrest on G2 phase in MCF-7 cells via ERalpha and PI3K/Akt pathways. J Cancer 6(4):319–326. doi:10.7150/jca.10733
19. Nagaraj G, Ma C (2015) Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-015-3316-4
20. Paez J, Sellers WR (2003) PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 115:145–167
21. Pu P, Kang C, Li J, Jiang H (2004) Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion. Tumour Biol: J Int Soc Oncodevelopmental Biol Med 25(4):172–178. doi:10.1159/000081099